8.1 Atherosclerosis, Peripheral Artery Disease & Diabetic Microangiopathy

8.1 Atherosclerosis, Peripheral Artery Disease & Diabetic Microangiopathy

Independent Study Guide Notice: Independent study guide by OpenExamPrep. This educational resource is developed independently by OpenExamPrep and is not sponsored, endorsed, or affiliated with the National Board of Podiatric Medical Examiners (NBPME) or Meazure Learning.

Introduction to Lower Extremity Vascular Pathology

Vascular disorders of the lower extremity represent a major component of podiatric pathology and general medical practice. Pathologic alterations within the arterial tree range from systemic large-vessel atherosclerosis and dystrophic medial calcification to microvascular endothelial dysfunction driven by chronic hyperglycemia. A comprehensive grasp of vascular pathophysiology, hemodynamic metrics, and histopathologic hallmarks is vital for clinical evaluation, limb preservation, and basic science board preparation.

---

Atherogenesis: The Cellular & Molecular Cascade

Atherosclerosis is a chronic, progressive fibroproliferative and inflammatory disease of the tunica intima of elastic and muscular arteries (such as the aorta, femoral, popliteal, and tibial arteries). The prevailing paradigm governing plaque initiation and progression is the "response-to-injury" hypothesis, originally formulated by Russell Ross.

+---------------------------------------------------------------------------------------------------+
|                                 CASCADE OF ATHEROGENESIS                                          |
+---------------------------------------------------------------------------------------------------+
|  Endothelial Injury & Dysfunction (loss of NO, upregulation of VCAM-1 / ICAM-1)                  |
|                                          ↓                                                        |
|  Subendothelial Infiltration & Oxidation of LDL Particles (OxLDL Formation)                      |
|                                          ↓                                                        |
|  Monocyte Recruitment, Diapedesis & Differentiation into Macrophages (M-CSF)                      |
|                                          ↓                                                        |
|  Unregulated Uptake of OxLDL via Scavenger Receptors (CD36, SR-A) → Foam Cells                   |
|                                          ↓                                                        |
|  Formation of Macroscopic Fatty Streaks (Early, Reversible Intimal Lesion)                       |
|                                          ↓                                                        |
|  Release of Mitogens (PDGF, FGF, TGF-β) → VSMC Migration from Media into Intima                  |
|                                          ↓                                                        |
|  VSMC Extracellular Matrix Secretion (Collagens I & III) → Fibrous Cap & Necrotic Core           |
|                                          ↓                                                        |
|  Macrophage MMP Secretion → Fibrous Cap Thinning & Rupture → Acute Atherothrombosis              |
+---------------------------------------------------------------------------------------------------+

1. Endothelial Dysfunction & Permeability

The initiating event is chronic, sublethal endothelial cell injury caused by disturbed laminar shear stress (turbulent flow at arterial bifurcations, such as the common femoral and popliteal branchings), hyperlipidemia, cigarette smoke toxins, systemic hypertension, and advanced glycation end-products.

• Loss of Endothelial Homeostasis: Injured endothelial cells demonstrate decreased bioavailability of nitric oxide (NO) and prostacyclin ($PGI_2$), impairing endothelium-dependent vasodilation while increasing endothelin-1 synthesis.
• Leukocyte Adhesion Molecule Expression: Activated endothelium upregulates surface adhesion molecules, including vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1), and selectins (E-selectin, P-selectin).

2. Lipoprotein Infiltration & Oxidation

Circulating low-density lipoprotein (LDL) particles traverse the hyperpermeable endothelial barrier into the subendothelial space of the tunica intima.

• Within the intima, LDL is trapped by extracellular matrix proteoglycans and undergoes oxidation by reactive oxygen species (ROS) generated by endothelial cells, adventitial fibroblasts, and resident macrophages, producing oxidized LDL (oxLDL).
• OxLDL is directly cytotoxic to endothelial cells, acts as a potent local chemoattractant for circulating monocytes, and stimulates endothelial cells to secrete monocyte chemoattractant protein-1 (MCP-1) and macrophage colony-stimulating factor (M-CSF).

3. Foam Cell Generation & Fatty Streak Formation

Circulating monocytes roll along the activated endothelium, firmly adhere via integrin-VCAM-1 interactions, and diapedese between endothelial junctions into the intima.

• Under the influence of M-CSF, monocytes differentiate into tissue macrophages.
• Macrophages express specialized scavenger receptors (notably CD36 and Scavenger Receptor A [SR-A]). Unlike the physiologic LDL receptor (ApoB/E receptor), scavenger receptors are not down-regulated by high intracellular cholesterol concentrations.
• Consequently, macrophages continuously ingest massive quantities of oxLDL, accumulating cytoplasmic lipid droplets filled with cholesterol esters, transforming into macrophage foam cells.
• Aggregations of foam cells beneath an intact endothelial lining produce the fatty streak—the earliest macroscopic manifestation of atherosclerosis. Fatty streaks appear as flat, elongated yellow streaks along the arterial lumen; they produce no luminal obstruction, are biologically reversible, and are uniformly present in the aortas of children and young adults.

4. Smooth Muscle Cell Migration & Fibrous Plaque Evolution

Progression from a simple fatty streak to an advanced fibroatheroma requires smooth muscle cell involvement:

• Activated foam cells, T lymphocytes ($Th1$ cells releasing IFN-γ), and adhering platelets release potent growth factors, particularly platelet-derived growth factor (PDGF), basic fibroblast growth factor (bFGF), and transforming growth factor-beta (TGF-β).
• Under these mitogenic signals, vascular smooth muscle cells (VSMCs) migrate from their normal residence in the tunica media, penetrate the internal elastic lamina, and populate the subendothelial tunica intima.
• Within the intima, VSMCs switch from a contractile phenotype to a synthetic phenotype. They proliferate and synthesize abundant extracellular matrix, predominantly type I and type III collagen, elastin, and proteoglycans.
• This newly synthesized matrix forms a dense, glistening white fibrous cap that walls off a central, avascular necrotic lipid core containing amorphous extracellular cholesterol crystals, necrotic foam cell debris, and calcium deposits.

5. Plaque Destabilization & Acute Atherothrombosis

Atherosclerotic plaques remain stable as long as the collagenous fibrous cap remains thick and intact. However, active local inflammation can destabilize the plaque:

• Macrophages within the plaque secrete matrix metalloproteinases (MMPs), including interstitial collagenases (MMP-1, MMP-8, MMP-13) and gelatinases (MMP-2, MMP-9), which enzymatically cleave and degrade fibrillar collagen within the fibrous cap.
• Simultaneously, IFN-γ secreted by activated T lymphocytes suppresses new collagen synthesis by intimal VSMCs.
• This produces a vulnerable plaque (thin-cap fibroatheroma / TCFA), characterized by a thin fibrous cap (<65 µm), a large lipid core (>40% of plaque volume), and dense macrophage infiltration.
• Hemodynamic shear stress triggers superficial plaque erosion or fissuring/rupture of the fibrous cap. Plaque rupture exposes circulating platelets directly to highly thrombogenic subendothelial type I collagen and tissue factor (TF).
• Rapid platelet adhesion (via glycoprotein Ib-IX-V binding to von Willebrand factor), platelet aggregation (via glycoprotein IIb/IIIa crosslinking fibrinogen), and thrombin generation precipitate acute atherothrombosis, resulting in sudden, critical luminal occlusion.

---

Mönckeberg Medial Calcific Sclerosis

First described by the German pathologist Johann Georg Mönckeberg in 1903, Mönckeberg medial calcific sclerosis (medial calcinosis) is a distinct degenerative condition characterized by dystrophic calcification of the tunica media in medium-sized and small muscular arteries.

Pathophysiologic Hallmarks

• Target Vessels: Muscular arteries of the extremities, particularly the tibial (anterior tibial, posterior tibial) and peroneal arteries, and less commonly the visceral and coronary vasculature.
• Demographics: Highly prevalent in elderly patients (>50–60 years), individuals with long-standing diabetes mellitus, and patients suffering from end-stage renal disease (ESRD) on maintenance hemodialysis.
• Cellular Mechanism: Rather than passive mineralization, medial sclerosis is an active, cell-regulated process. Elevated serum phosphate and calcium levels, uremic toxins, and oxidative stress induce vascular smooth muscle cells in the media to undergo osteogenic transdifferentiation into osteoblast-like cells. These transdifferentiated cells upregulate osteogenic transcription factors (such as Runx2/Cbfa1 and Msx2) and secrete bone morphogenetic protein-2 (BMP-2), resulting in hydroxyapatite crystal deposition along the internal elastic lamina and concentric lamellae of the tunica media.
• Intimal Sparing: Unlike atherosclerosis, the tunica intima is entirely spared, and the endothelial surface remains smooth. The calcification does not encroach upon or occlude the arterial lumen, and it does not provoke primary thrombosis.

Plain Radiographic & Clinical Significance

• Radiographic Appearance: Medial calcific sclerosis is readily identifiable on standard non-contrast plain radiographs of the foot, ankle, and lower leg. It manifests as continuous, uniform, dense, parallel linear radiopacities tracking the anatomical course of the tibial and pedal arteries, classically termed "pipestem" or "railroad-track" calcifications.
• Hemodynamic Non-Compressibility: The rigid, calcified arterial walls transform the vessel into an incompressible tube that resists collapse under standard external pneumatic cuff compression.

Alternative Diagnostic Modalities in Medial Sclerosis

1. Toe-Brachial Index (TBI): The digital arteries of the hallux and lesser digits are terminal arterioles that possess minimal tunica media and are spared from Mönckeberg medial sclerosis. Measuring digital systolic pressure with a miniature digital cuff and photoplethysmography (PPG) provides an accurate assessment of distal arterial perfusion. A normal TBI is >0.70. A TBI <0.70 diagnosticates arterial insufficiency, while a TBI <0.25–0.30 confirms critical limb ischemia.
2. Pulse Volume Recording (PVR): Segmental air plethysmography evaluates volumetric arterial pulse contours independent of vessel wall calcification. Normal PVR exhibits a steep systolic upstroke, sharp systolic peak, prominent dicrotic notch, and gradual downslope (triphasic equivalent). Loss of the dicrotic notch and flattening of the wave (biphasic or monophasic) confirms arterial stenosis regardless of cuff incompressibility.
3. Transcutaneous Oxygen Pressure ($TcPO_2$): Direct microvascular measurement of dermal capillary oxygen delivery. Values >40 mmHg indicate adequate microcirculatory perfusion and healing potential; values <30 mmHg reflect severe impairment; values <20 mmHg correlate with non-healing ischemic ulcers.

---

Arteriosclerosis Classification: Comparative Histopathology

The term arteriosclerosis ("hardening of the arteries") encompasses three histopathologically distinct vascular entities that must be strictly differentiated on board examinations.

---

Peripheral Artery Disease (PAD): Hemodynamics & Staging

Peripheral Artery Disease (PAD) of the lower extremities is the clinical manifestation of flow-limiting atherosclerotic stenoses within the abdominal aorta, iliac, femoropopliteal, and infrapopliteal (tibial/peroneal) arterial networks.

Clinical Manifestations

1. Intermittent Claudication:
   • The cardinal early symptom of lower extremity arterial occlusive disease.
   • Characterized by exertional cramping, aching, heaviness, or muscle fatigue occurring in functional muscle groups (calf, thigh, buttock) during ambulation.
   • Strict Diagnostic Criteria: Pain is reproducibly elicited by a constant walking distance, increases with continued walking, and is completely relieved within 2 to 5 minutes of rest in a stationary standing position (unlike neurogenic claudication / spinal stenosis, which requires lumbar flexion or sitting to obtain relief).
   • Anatomical localization corresponds to the level of arterial obstruction: superficial femoral artery occlusion causes calf claudication; common femoral occlusion causes thigh claudication; aortoiliac occlusion causes buttock and hip claudication.
2. Leriche Syndrome (Aortoiliac Occlusive Disease Triad):
   • Severe chronic atherosclerotic occlusion of the distal abdominal aorta and common iliac arteries produces a classic clinical triad:
     1. Bilateral claudication of the buttocks, hips, and thighs.
     2. Absent or profoundly diminished bilateral femoral pulses.
     3. Erectile dysfunction (impotence in males, resulting from internal iliac / hypogastric arterial insufficiency).
3. Critical Limb Ischemia (CLI) / Chronic Limb-Threatening Ischemia (CLTI):
   • Represents end-stage arterial insufficiency where resting distal perfusion is inadequate to sustain basal tissue metabolic requirements.
   • Ischemic Rest Pain: Severe, unrelenting, burning or aching discomfort localized to the forefoot and digits. Pain is exacerbated by horizontal recumbency and limb elevation (loss of gravitational hydrostatic pressure), frequently waking the patient at night. Patients learn to obtain transient gravitational relief by hanging the affected foot over the side of the bed or sleeping in an upright chair.
   • Ischemic Ulceration: Deep, painful, "punched-out" ulcers with distinct, pale, non-bleeding margins and a dry, necrotic, yellow-gray or black base lacking healthy granulation tissue. Commonly located on distal toe tips, interdigital web spaces, and the lateral foot border.
   • Dry Gangrene: Coagulative necrosis resulting from profound arterial ischemia without concurrent bacterial infection. The affected digits become shriveled, mummified, hard, cold, black, and demarcated from adjacent viable skin by an inflammatory erythematous border.

Ankle-Brachial Index (ABI) Diagnostic Framework

The Ankle-Brachial Index is the ratio of the highest systolic blood pressure measured at the ankle (dorsalis pedis or posterior tibial artery) to the highest systolic blood pressure measured in either brachial artery:

$\text{ABI} = \frac{\text{Highest Ankle Systolic Pressure (DP or PT)}}{\text{Highest Brachial Systolic Pressure (Left or Right)}}$

---

Vasculitides & Vasospastic Disorders

Thromboangiitis Obliterans (Buerger Disease)

Thromboangiitis obliterans is a distinctive non-atherosclerotic, highly inflammatory, vaso-occlusive vasculopathy.

• Demographics: Classically affects young men under 40–45 years of age with an extensive, heavy history of cigarette smoking or tobacco consumption.
• Vessel Infiltration: Segmental involvement of small and medium-sized muscular arteries and veins of the distal extremities (tibial, plantar, digital vessels).
• Histopathologic Hallmarks: Unlike atherosclerosis, Buerger disease is an acute and chronic panvasculitis involving all three tunics of the vessel wall. It is characterized by an intraluminal, highly cellular, occlusive thrombus packed with polymorphonuclear neutrophils (PMNs) forming distinct microabscesses and multinucleated giant cells. Crucially, the internal elastic lamina remains intact, which reliably differentiates Buerger disease from necrotizing systemic vasculitides (such as polyarteritis nodosa).
• Clinical Presentation: Manifests as ischemic digital rest pain, cold sensitivity, Raynaud phenomenon, non-healing digital ulcerations, and spontaneous digital gangrene. A unique diagnostic feature is recurrent migratory superficial thrombophlebitis (tender, erythematous cords along superficial veins of the leg or foot).
• Definitive Treatment: Absolute and permanent cessation of all tobacco and nicotine products (including e-cigarettes and nicotine replacement therapy). Continued smoking invariably results in progressive digital amputation.

Raynaud Phenomenon: Primary vs. Secondary

Raynaud phenomenon is an episodic, reversible vasospastic disorder of digital arteries and cutaneous precapillary arterioles in response to cold temperatures or acute emotional stress.

+---------------------------------------------------------------------------------------------------+
|                                 TRIPHASIC COLOR SEQUENCE OF RAYNAUD                               |
+---------------------------------------------------------------------------------------------------+
| 1. PALLOR (White):      Sudden digital arteriolar vasospasm → Total cutaneous ischemia           |
|                                          ↓                                                        |
| 2. CYANOSIS (Blue):     Stagnant, deoxygenated blood pooling in dilated capillaries and venules   |
|                                          ↓                                                        |
| 3. RUBOR (Red):         Re-warming → Reactive hyperemia, throbbing pain, tingling, hyperperfusion |
+---------------------------------------------------------------------------------------------------+

• Primary Raynaud Phenomenon (Raynaud Disease): Represents an idiopathic, exaggerated physiologic vasospastic response. Most common in young females (aged 15–30); symmetric digital involvement; completely normal nailfold capillaroscopy (no capillary dropout); negative antinuclear antibody (ANA) titers; and complete absence of digital ulceration, gangrene, or systemic autoimmune disease.
• Secondary Raynaud Phenomenon (Raynaud Syndrome): Arises secondary to an underlying systemic autoimmune connective tissue disease, overwhelmingly systemic sclerosis (scleroderma) and CREST syndrome (Calcinosis cutis, Raynaud phenomenon, Esophageal dysmotility, Sclerodactyly, Telangiectasia), as well as systemic lupus erythematosus (SLE) or rheumatoid arthritis. Secondary Raynaud is characteristically asymmetric, intensely painful, manifests in older individuals, demonstrates distorted, enlarged capillary loops with avascular drop-out zones on nailfold capillaroscopy, exhibits positive autoantibodies (anti-Scl-70, anti-centromere), and frequently causes painful digital pitting scars, ischemic ulcerations, and gangrene.

---

Diabetic Microangiopathy: Biochemical Pathways & Histology

Chronic, sustained hyperglycemia in diabetes mellitus induces profound structural and functional derangements within the microvasculature (arterioles, capillaries, venules). Two biochemical cascades predominate:

1. The Advanced Glycation End-Product (AGE-RAGE) Axis

• Non-Enzymatic Glycation: Excess circulating glucose non-enzymatically condenses with free amino groups of structural proteins (such as type IV collagen and laminin), forming reversible Schiff bases and Amadori products (analogous to HbA1c formation).
• Irreversible Cross-Linking: Through slow chemical rearrangements, these products transform into stable, irreversible Advanced Glycation End-products (AGEs).
• Biological Consequences:
  • AGEs covalently cross-link type IV collagen within capillary basement membranes, preventing normal molecular turnover, accelerating endothelial cell leakage, and trapping extravasated LDL.
  • AGEs bind to their specific surface receptor, RAGE (Receptor for Advanced Glycation End-products), present on vascular endothelial cells, smooth muscle cells, and macrophages.
  • RAGE activation triggers intracellular transcription factor NF-κB, stimulating production of pro-inflammatory cytokines (IL-1, TNF-α), reactive oxygen species (ROS), endothelin-1, and vascular endothelial growth factor (VEGF), inducing pathological microvascular hyperpermeability and proliferation.

2. The Polyol (Sorbitol) Pathway & Oxidative Stress

In tissues that do not require insulin for cellular glucose uptake (including Schwann cells of peripheral nerves, vascular pericytes, renal mesangial cells, and the crystalline lens of the eye), hyperglycemia leads to intracellular glucose overload:

$\text{Glucose} + \text{NADPH} + \text{H}^+ \xrightarrow{\text{Aldose Reductase}} \text{Sorbitol} + \text{NADP}^+$

$\text{Sorbitol} + \text{NAD}^+ \xrightarrow{\text{Sorbitol Dehydrogenase}} \text{Fructose} + \text{NADH} + \text{H}^+$

• Osmotic Damage: Aldose reductase reduces excess intracellular glucose into sorbitol. Sorbitol is a polar, membrane-impermeable polyol that diffuses poorly across cell membranes, causing intracellular osmotic swelling and cellular lysis.
• NADPH Depletion & Redox Failure: More critically, aldose reductase consumes massive quantities of NADPH. Intracellular NADPH is the obligate cofactor required by glutathione reductase to regenerate reduced glutathione (GSH) from oxidized glutathione (GSSG):

$\text{GSSG} + \text{NADPH} + \text{H}^+ \xrightarrow{\text{Glutathione Reductase}} 2\,\text{GSH} + \text{NADP}^+$

• When NADPH is consumed by aldose reductase, reduced glutathione is severely depleted. Because GSH is the primary cellular scavenger of hydrogen peroxide ($H_2O_2$) via glutathione peroxidase, its loss exposes endothelial cells, pericytes, and Schwann cells to unchecked reactive oxygen species (ROS), driving lipid peroxidation, DNA damage, and apoptosis.

3. Histopathologic Hallmarks of Diabetic Microangiopathy

• Capillary Basement Membrane Thickening: The pathognomonic structural lesion of diabetic microangiopathy is diffuse, concentric thickening of the capillary basement membrane composed of disorganized type IV collagen and laminin. Despite the marked thickening, diabetic capillaries are paradoxically leaky and hyperpermeable to plasma solutes and proteins.
• Hyaline Arteriolosclerosis: Diffuse, homogeneous, glassy eosinophilic proteinaceous thickening of the arteriolar media and intima with progressive narrowing of the arteriolar lumen, secondary to leakage of plasma proteins across injured endothelium and excessive matrix production by smooth muscle cells.
• Diabetic Nephropathy: In renal glomeruli, microangiopathy manifests as diffuse mesangial matrix expansion and nodular glomerulosclerosis featuring pathognomonic Kimmelstiel-Wilson nodules (laminated, PAS-positive, spherical eosinophilic acellular mesangial expansions), leading to heavy proteinuria, microalbuminuria, and progressive renal failure.